A neuronal isoform of nitric oxide synthase expressed in pancreatic β-cells controls insulin secretion

Diabetes

Volumn 50, Issue 6, 2001, Pages 1311-1323

  Lajoix, Anne Dominique ^a   Reggio, Hubbert ^b   Chardès, Thierry ^a   Péraldi Roux, Sylvie ^a   Tribillac, Florence ^c   Roye, Michèle ^a   Dietz, Samuel ^a   Broca, Christophe ^a   Manteghetti, Michèle ^a   Ribes, Gérard ^a   Wollheim, Claes B ^d   Gross, René ^a,e  

^a CNRS   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c UNIV MONTPELLIER   (France)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^e Laboratoire de Pharmacologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CLOTRIMAZOLE; GLUCOSE; INSULIN; ISOENZYME; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SUBSTRATE; INSULIN RELEASE; MALE; MITOCHONDRION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SECRETORY GRANULE;

EID: 0034985431     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.6.1311     Document Type: Article

References (64)

1. Nitric oxide: Physiology, pathophysiology, and pharmacology
2. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter
3. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
4. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation
5. Nitric oxide: A cytotoxic activated macrophage effector molecule
6. The inducible form of nitric oxide synthase (iNOS) in insulin-producing cells
7. Neuronal NADPH diaphorase is a nitric oxide synthase
8. Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides
9. Nitric oxide and arginine-evoked insulin secretion
10. Comparative distribution of nitric oxide synthase (NOS) in pancreas of the dog and rat: Immunocytochemistry of neuronal type NOS and histochemistry of NADPH-diaphorase
11. Histochemical demonstration of NADPH-diaphorase activity, a marker for nitric oxide synthase, in neurons of the rat pancreas
12. Neuronal and endothelial nitric oxide synthase immunoreactivity and NADPH-diaphorase staining in rat and human pancreas: Influence of fixation
13. 2+-signaling in rat pancreatic β-cells
14. Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: An immunocytochemical and confocal microscopical study
15. The early phase of glucose-stimulated insulin secretion requires nitric oxide
16. Rat brain NADPH-dependent diaphorase: A possible relationship to cytochrome P450 reductase
17. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P450 reductase
18. Neuronal nitric oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle
19. Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans
20. Nitric oxide production is not a prerequisite for arginine induced insulin secretion
21. Involvement of nitric oxide in the generation of the biphasic pattern of β-cell response to glucose
22. G-nitro-L-arginine methyl ester
23. Inhibition of islet nitric oxide synthase increases arginine-induced insulin release
24. Nitric oxide (nitrogen monoxide, NO) stimulates insulin secretion by inducing calcium release from mitochondria
25. 2+ mobilization and increases secretion of incorporated 5-hydroxytryptamine in rat pancreatic β-cells
26. Endogenous nitric oxide inhibits glucose-induced insulin secretion by suppression of phosphofructokinase activity in pancreatic islets
27. Mechanisms involved in the effect of nitric oxide synthase inhibition on L-arginine-induced insulin secretion
28. Multiple catalytic functions of brain nitric oxide synthase: Biochemical characterization, cofactor-requirement and the role of N-omega-hydroxy-L-arginine as an intermediate
29. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine
30. 2+/ calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase
31. Electron transfer in the nitric-oxide synthases: Characterization of L-arginine analogs that block heme iron reduction
32. The dual mode of inhibition of calmodulin-dependent nitric-oxide synthase by antifungal imidazole agents
33. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines
34. Standardization of a digestion-filtration method for isolation of pancreatic islets
35. Immunocytochimie et ultracryotomie
36. Etude expérimentale d'un nouveau sulfamide hypoglycémiant particuliérement actif, le HB 419 ou glibenclamide
37. Coated charcoal immunoassay of insulin
38. Regulation of biosynthesis of nitric oxide
39. 3 and chromaffin cells by imidazole antimycotics and other cytochrome P450 blockers
40. + channels by cytochrome P-450 inhibitors
41. Electrophysiology of the pancreatic β-cell
42. Stimulus-secretion coupling of arginine induced insulin release: Metabolism of L-arginine and L-ornithine in pancreatic islets
43. On the origin of pancreatic endocrine cells
44. Subcellular localization of neuronal nitric oxide synthase in the brain of a teleost: An immunoelectron and confocal microscopical study
45. Expression and regulation of endothelial nitric oxide synthase
46. Perspective series: Nitric oxide and nitric oxide synthases: Nitric oxide synthases: Which, where, how and why?
47. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy
48. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells
49. Effects of the nitric oxide synthase inhibitor N omega nitro-L-arginine methyl ester on electrical activity and ion channels of mouse pancreatic B cells
50. Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic β-cells
51. G-nitro-L-arginine
52. + channels
53. The inhibition of the constitutive and inducible nitric oxide synthase isoform by indazole agents
54. Comparison of substrate and inhibitor specificity of arginase and nitric oxide (NO) synthase for arginine analogues and related compounds in murine and rat macrophages
55. G-hydroxy-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase
56. Human arginase isozymes
57. Glyceraldehyde phosphate and methyl esters of succinic acid: Two "new" potent insulin secretagogues
58. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase
59. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase
60. Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic β-cells
61. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis
62. Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets: Further implication of cytosolic NADPH in insulin secretion
63. Nitric oxide synthase activity in mitochondria
64. Neuronal nitric oxide synthase: Expression in Escherichia coli, irreversible inhibition by phenyldiazene, and active site topology